Filing Details
- Accession Number:
- 0001213900-17-006435
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-13 16:45:45
- Reporting Period:
- 2017-06-09
- Filing Date:
- 2017-06-13
- Accepted Time:
- 2017-06-13 16:45:45
- SEC Url:
- Form 4 Filing
Issuer
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1015994 | R Paul Gudonis | One Broadway, 14Th Floor Cambridge MA 02142 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-09 | 69,726 | $0.00 | 341,054 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2017-06-09 | 57,489 | $0.00 | 398,543 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2017-06-09 | 21,564 | $0.00 | 420,107 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2017-06-09 | 14,000 | $0.00 | 434,107 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | SERIES A-1 CONVERTIBLE PREFERRED STOCK | Disposition | 2017-06-09 | 69,726 | $0.00 | 69,726 | $0.00 |
| Common Stock | SERIES B-1 CONVERTIBLE PREFERRED STOCK | Disposition | 2017-06-09 | 57,489 | $0.00 | 57,489 | $0.00 |
| Common Stock | 8 % SUBORDINATE CONVERTIBLE NOTE | Disposition | 2017-06-09 | 21,564 | $5.18 | 21,564 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The Series A-1 Convertible Preferred Stock converted into common stock on a 1-for-1 basis upon completion of the Company's initial public offering and has no expiration date.
- The Series B-1 Convertible Preferred Stock converted into common stock on a 1-for-1 basis upon completion of the Company's initial public offering and has no expiration date.
- The 8% subordinate convertible note was converted into common stock at a price of $5.18 per share upon completion of the Company's initial public offering.
- The Common Stock was acquired in the Company's initial public offering for $7.50 per share.
Billionaire Hedge Funds
